Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Humana Specialty Pharmacy Wins National Award for Third Consecutive Year


Humana Specialty Pharmacy has received the Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the third year in a row. The award, presented by Zitter Health Insights, a division of MMIT, recognizes the highest quality in customer service and optimal patient care by a specialty pharmacy.

Humana Specialty Pharmacy, a part of Humana Pharmacy, manages therapies for chronic and complex illnesses while integrating pharmacy and medical needs to provide whole person health care for patients. Humana Specialty Pharmacy customers receive both clinical and educational services customized to their individual needs and treatment goals.

“We are honored to receive this national award that highlights our work to deliver personalized care and support to the patients we serve,” said Adam Hanauer, Vice President, Humana Specialty Pharmacy. “The COVID-19 outbreak has reinforced the strength of our integrated care delivery strategy, which at its core is about helping our patients achieve their best health. We are grateful for our incredible leadership team, technicians, pharmacists, nurses, care coordinators, and all the support teams who are deeply committed to putting the patient at the center of everything we do.”

The award reflects Humana’s Human Care approach to making the healthcare experience better, more personal and more caring. Humana Specialty Pharmacy provides a personalized experience throughout treatment, offering access to a disease management team member, clinical nurses and pharmacists who are experts in specialty conditions. Humana Specialty Pharmacy also applies a practical approach to managing side effects and supports patients who apply for patient assistance programs to cover the costs of their specialty drugs.

The criteria for the Specialty Pharmacy Patient Choice award was formulated by a committee of individuals representing pharmaceutical manufacturers, payers, trade organizations, consultants and equity research firms.

For more information about Humana Specialty Pharmacy, visit: www.humanaspecialty.com.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005651/en/

Humana Inc. Aktie

325,60 €
0,43 %
Humana Inc. kann heute leichte Zuwächse vorweisen. Die Aktie notiert im Vergleich zu gestern um 0,43 % höher.
Klare Kaufstimmung: Humana Inc. hat 24 Buy-Einschätzungen und keine Sell-Einschätzung.
Ein Kursziel von 381 € für Humana Inc. impliziert ein leicht positives Wachstum gegenüber dem aktuellen Kurs von 325.6 €.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare